IPO Size
Price Band
Minimum Lot Size
Face Value
Employee Discount
Retail Allocation
Issue Open Date
Issue Close Date
Listing Date
About the Company:
Clean Science and Technology is a globally focused entirely on developing newer technologies using in-house catalytic processes, which are eco-friendly and cost competitive. This has enabled them to emerge as the largest manufacturer globally of certain specialty chemicals in terms of installed manufacturing capacities as of March 31, 2021. The company has continued its focus on product identification, process innovation, catalyst development, significant scale of operations as well as our measures towards strategic backward integration that have all contributed to their success as one of the fastest growing and among the most profitable specialty chemical companies globally. The company’s name was changed to ‘Clean Science and Technology Private Limited’ in 2006, to reflect our vision of focusing on sustainable chemistry led by innovative technology and lower effluents. They manufactures functionally critical specialty chemicals such as Performance Chemicals (i.e. MEHQ, BHA and AP), Pharmaceutical Intermediates (i.e. Guaiacol and DCC), and FMCG Chemicals (i.e. 4-MAP and Anisole). Within 17 years of incorporation, we have grown to be the largest manufacturer globally of MEHQ, BHA, Anisole and 4-MAP, in terms of installed manufacturing capacities.
Outstanding Litigation:
S.No. | 1 - Company | 2 - Directors | 3 - Promoters | |||
Entity Name | By the Company | Against the Company | By the Subsidiaries | Against the Subsidiaries | By the Promoters | Against the Promoters |
Criminal cases | 7 | 2 | - | 2 | - | - |
Material civil cases | 7 | - | - | - | - | - |
Taxation matters | - | 1 | - | - | - | - |
Regulatory Procedings | - | - | - | - | - | - |
Amt. (In Million Rs.) | 2,081.16 | 2.38 | - | Not Quantifiable | Non-Quantifiable | Non-Quantifiable |
Financial Statements:
Income Statement (In Millions) | FY21 | FY20 | FY19 | |
Gross Operating Income | 5380.71 | 4301.65 | 4045.63 | |
Cost of Employee & Inventory | 1671.4 | 1602.51 | 1960.77 | |
Other Expenses | 863.34 | 737.63 | 608.84 | |
EBITDA | 2845.97 | 1961.51 | 1476.02 | |
Depreciation | 172.05 | 137.14 | 110.33 | |
Interest | 0.91 | 1.21 | 0.33 | |
Profit Before Tax | 2673.01 | 1823.16 | 1365.36 | |
Tax | 689.21 | 426.85 | 388.78 | |
Profit After Tax | 1983.8 | 1396.31 | 976.58 |
The promoters of the company are Ashok Ramnarayan Boob, Krishnakumar Ramnarayan Boob, Siddhartha Ashok Sikchi, and Parth Ashok Maheshwari
In the listed space, the company faces tough competition from Rossari Biotech, Fine Organics, Camlin Fine Sciences, PI Industries and Navin Fluorine Limited.
The issue size of 1,546.62 crores is a complete Offer for Sale comprises sale of up to 17.18 million shares by Ashok Ramnarayan Boob, Krishnakumar Ramnarayan Boob, Siddhartha Ashok Sikchi and Parth Ashok Maheshwari.